- Per. of shares (as a % of the total sh. of prom. and promoter group)----- - Per. of shares (as a % of the total Share Cap. of the company)----- Advisory Alert: It has come to our attention ...

Alembic Ltd share price was down by -3.80% from the previous closing price of ₹103.62. Who are peers of Alembic Ltd? The peers of Alembic Ltd are DLF Ltd, Macrotech Developers Ltd, Godrej ...

Drug firm Alembic Pharmaceuticals Ltd on Friday (February 14) said it has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (FDA) for its solid oral ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Alembic Ltd. key Products/Revenue Segments include Income From Real Estate Development, Rent, Job Work, API, Other Operating Revenue and Export Incentives for the year ending 31-Mar-2024.For the ...

Alembic Pharmaceuticals has received USFDA approval for its generic version of Brexpiprazole tablets, used to treat major depressive disorder. The approval covers strengths ranging from 0.25 mg to ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Following an inspection carried out from Nov 14-22 2024, the facility was cited as being ‘VAI’ (Voluntary Action Indicated).

Please find attached the Intimation of Issuance of Corporate Guarantee for providing the working capital facilities to Alembic Pharmaceuticals SpA Chile, a wholly owned subsidiary of the Company.